The Hidden Epidemic of Smell Loss (Hyposmia) in the United States
DOI:
https://doi.org/10.17140/OTLOJ-1-e001Abstract
There is a hidden epidemic of hyposmia in the United States. While most otolaryngologists may see one or two patients with hyposmia yearly there are as many as 21 million people in the United States with hyposmia. Most of these patients experienced hyposmia following an influenza-like infection.
References
Henkin RI. Report on a survey on smell in the US. Olfact Rev. 1987; 1: 1-8.
Henkin RI, Levy LM, Fordyce A. Taste and smell function in chronic disease: a review of clinical and biochemical evaluation of taste and smell dysfunction in over 5000 patients at The Taste and Smell Clinic in Washington, DC. Am J Otolaryngol. 2013; 34(5): 477-489. doi: 10.1016/j.amjoto.2013.04.006
Henkin RI, Velicu I, Schmidt L. An open-label controlled trial of theophylline for treatment of patients with hyposmia. Am J Med Sci. 2009; 337: 396-406. doi: 10.1097/MAJ.0b013e3181914a97
Henkin RI, Schultz M, Minnick-Poppe L. Intranasal theophylline treatment of hyposmia and hypogeusia: a pilot study. Arch Otolaryngol Head Neck Surg. 2012; 138(11): 1064-1070. doi: 10.1001/2013.jamaoto.342 Otolaryngol Open J Page e2
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Otolaryngology (OOJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.